These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Smooth muscle relaxing, acute and long-term blood pressure lowering effects of atriopeptins. Structure-activity relationship.
    Author: De Mey JG, Cuthbert C, von Szendroi KG, van Malder G, Roba J.
    Journal: J Pharmacol Exp Ther; 1987 Mar; 240(3):937-43. PubMed ID: 2951517.
    Abstract:
    The relationship between the arterial relaxing, acute and long-term blood pressure lowering effects of atriopeptins were analyzed. We therefore evaluated effects of atriopeptin (103-126), i.e., atriopeptin III, and compared them to those of selected analogs. Atriopeptin (103-126) relaxed isolated aortas (1-30 nM) and lowered systolic blood pressure in conscious spontaneously hypertensive rats when high doses (4-400 nmol/kg i.v.) were administered acutely or low doses (0.4-4.0 nmol/kg/hr i.v.) were administered chronically. The relaxing effect was not affected by amino-terminal extension with up to four amino acids and by carboxy-terminal deletion of one amino acid. Further deletions lowered the relaxing potency. The observed maximal amplitude of the acute blood pressure lowering was reduced drastically by carboxy-terminal deletion of even one amino acid. This was prevented by substitution of the carboxy-terminal acid by an amide. Although not affecting the amplitude, amino-terminal extension with Arg or Arg-Arg prolonged markedly the duration of action of the acute effect. Chronic administration of atriopeptin (103-126), (103-125) and (103-123) affected blood pressure similarly. These findings illustrate different structure-activity relationships for the smooth muscle relaxing, acute and long-term antihypertensive activities of atriopeptins. From this it is suggested that the carboxy-terminal amino acids modulate differently the biological activities of atriopeptins, that amino-terminal amino acids modulate the duration of action of the acute in vivo effects and that the long-term antihypertensive effects of atriopeptins are not related directly to their arterial smooth muscle relaxing and acute blood pressure lowering effects.
    [Abstract] [Full Text] [Related] [New Search]